Additional information

Laboratory

Exult Diagnostics, Dr. Lal PathLabs

Reviews

There are no reviews yet.

Be the first to review “MULTIPLE MYELOMA COMPREHENSIVE PROFILE”

Your email address will not be published. Required fields are marked *

MULTIPLE MYELOMA COMPREHENSIVE PROFILE

 15000

EX1534      MULTIPLE MYELOMA COMPREHENSIVE PROFILE
Specimen: 5 mL (3 mL min.) serum from 1 SST AND 3 mL (2 mL min.) whole blood in 1 Lavender Top (EDTA) tube. Ship refrigerated. Overnight fasting is preferred AND 3 mL (1 mL min.) Bone Marrow (first pull aspirate) in 1 Green Top (Sodium Heparin) tube AND 1 or 2 unstained Bone marrow smears to be made at source. Mix thoroughly & Ship immediately at 18-22°C or at 4-8°C. DO NOT FREEZE.
Stability:
Room Refrigerated Frozen
Ship at specified temperatures Ship at specified temperatures Ship at specified temperatures
Method: Capillary electrophoresis, Agarose Gel Electrophoresis, Immunoturbidimetry, CLIA Spectrophotometry, Electrical impedance, VCS Nephelometry, Flow cytometry
Comment: It is recommended that specimens arrive within 48 hours of drawing. The percentage of clonal plasma cells estimated by flow cytometry is affected by specimen processing and antigen loss with specimen aging.
Report: Contact us to know the TAT.
Usage: This profile helps to track the progression of Myeloma and the response to treatment. Detection of minimal residual disease in Multiple Myeloma predicts outcome, helps identify an impending relapse and enables early intervention, better post-transplant surveillance, and better clinical management of patients.
Doctor Specialty: Oncologist
Disease: Multiple Myeloma
Components: *CBC *Urea *Creatinine *Calcium, total *Albumin *LDH *Beta 2 Microglobulin *Protein electrophoresis, serum *Immunotyping, serum *Kappa / Lambda Light Chains Free, serum *Immunoglobulin Profile, serum *MRD for Multiple Myeloma
Courier Charges:
Home Collection: Available (*T&C Apply)
Department: FLOW CYTOMETRY
Pre Test Information: Overnight fasting is preferred. The following information is mandatory: Sample time point (Chemotherapy time points); Previous diagnostic immunophenotype report; Clinical History to include if the patient is on anti-CD38 therapy; Original TRF; Date and time when the sample was drawn.